Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Benzinga·04/02/2026 12:02:14

Listen to the news

U.S. stock futures were lower this morning, with the Dow futures falling around 400 points on Thursday.

Shares of Alto Neuroscience Inc (NYSE:ANRO) fell sharply in pre-market trading after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.

Alto Neuroscience shares dipped 13.6% to $20.16 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

Akso Health Group – ADR (NASDAQ:AHG) fell 9.4% to $2.10 in pre-market trading.
SharonAI Holdings Inc (NASDAQ:SHAZ) fell 8.8% to $25.19 in pre-market trading. SharonAI Holdings shares jumped around 22% on Wednesday after the company announced the signing of a five-year TCV AI infrastructure agreement with ESDS Software Solutions.
Progress Software Corp (NASDAQ:PRGS) fell 8.3% to $23.00 in pre-market trading.
Immunovant Inc (NASDAQ:IMVT) fell 8.3% to $23.02 in pre-market trading as the company announced Phase 3 study results for Batoclimab in Thyroid Eye Disease (TED).
Americas Gold and Silver Corporation (NYSE:USAS) fell 8.1% to $5.14 in pre-market trading after gaining 7% on Wednesday.
TRX Gold Corp (NYSE:TRX) fell 7.2% to $1.42 in pre-market trading.
Rezolve AI PLC (NASDAQ:RZLV) fell 7% to $2.91 in pre-market trading after jumping 22% on Wednesday.
Avino Silver & Gold Mines Ltd (NYSE:ASM) fell 6% to $6.20 in pre-market trading after gaining 4% on Wednesday.

Photo via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number :+852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email :service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation :marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English